ArticleJHLT open2026
Dual-energy CT based scoring to estimate perfusion changes after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Balloon pulmonary angioplasty (BPA) is a treatment option for chronic thromboembolic pulmonary hypertension (CTEPH) patients ineligible for surgery. Evaluation of disease severity and treatment response rely on right heart catheterization (RHC) and clinical evaluation. Lung perfusion is often not considered as evaluation requires techniques beyond the capabilities of computed tomography pulmonary angiography (CTPA). Dual-energy (DECT-PA) provides traditional diagnostic images, and lung perfusion blood volume (PBV) images to obtain perfusion defect (PD) scores. We assessed whether PD score could detect changes in pulmonary perfusion before, during, and after BPA treatment in CTEPH patients. Methods: This prospective study included patients (n=17) diagnosed with CTEPH and allocated to BPA intervention. Patients underwent DECT-PA during their diagnostic workup, 2-3 weeks after the second treatment, and 3-6 months after the last treatment. Two observers graded the severity of perfusion defects on PBV images, obtaining the PD score. RHC, quantitative perfusion, and clinical parameters were recorded. Results: PD score improved from baseline (11±4.7) to second scan (8.1±3.4, Conclusions: Perfusion defect score from DECT-PA can estimate changes in pulmonary perfusion before, during, and after BPA interventions. Though intra-observer agreement is substantial, inter-observer agreement is variable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.